Cargando…

Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients

Cardiovascular diseases are currently one of the most important causes of morbidity and mortality in liver transplant patients over the long term. Therefore, evaluating prognostic factors for cardiovascular events (CVEs) in this population is essential for taking preventive measures. The aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cola, Simone, Cusi, Giulia, Lapenna, Lucia, Gazda, Jakub, Fonte, Stefano, Mattana, Marco, Mennini, Gianluca, Pasqualetti, Patrizio, Merli, Manuela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313467/
https://www.ncbi.nlm.nih.gov/pubmed/37396501
http://dx.doi.org/10.1155/2023/2199193
_version_ 1785067131968159744
author Di Cola, Simone
Cusi, Giulia
Lapenna, Lucia
Gazda, Jakub
Fonte, Stefano
Mattana, Marco
Mennini, Gianluca
Pasqualetti, Patrizio
Merli, Manuela
author_facet Di Cola, Simone
Cusi, Giulia
Lapenna, Lucia
Gazda, Jakub
Fonte, Stefano
Mattana, Marco
Mennini, Gianluca
Pasqualetti, Patrizio
Merli, Manuela
author_sort Di Cola, Simone
collection PubMed
description Cardiovascular diseases are currently one of the most important causes of morbidity and mortality in liver transplant patients over the long term. Therefore, evaluating prognostic factors for cardiovascular events (CVEs) in this population is essential for taking preventive measures. The aim of this study was to identify the impact of diabetes and other metabolic disorders on CVEs in liver transplant patients. Three hundred fifty-six liver transplant recipients who survived at least 6 months after surgery were enrolled. Patients were followed for a median time of 118 months (12–250 months). All cardiovascular events were carefully recorded and detailed in the patients' charts. Demographic data, diabetes, hypertension, dyslipidemia, weight changes, and a diagnosis of metabolic syndrome both before and after transplantation were noted to assess their possible relationship with CVE. The presence of a diagnosis of metabolic-associated fatty liver disease (MAFLD) was also evaluated. Immunosuppressive therapy was included in the analysis. Diabetes mellitus (DM), especially when present before transplantation, was strongly associated with CVEs (hazard risk HR 3.10; 95% confidence interval CI: 1.60–6.03). Metabolic syndrome was found to be associated with CVEs in univariate analysis (HR 3.24; 95% CI: 1.36–7.8), while pretransplantation and de novo MAFLD were not. Immunosuppressive therapy had no influence on predisposing transplanted patients to CVEs during follow-up. Further prospective studies may be useful in investigating the risk factors for CVEs after liver transplantation and improving the long-term survival of transplant patients.
format Online
Article
Text
id pubmed-10313467
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103134672023-07-01 Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients Di Cola, Simone Cusi, Giulia Lapenna, Lucia Gazda, Jakub Fonte, Stefano Mattana, Marco Mennini, Gianluca Pasqualetti, Patrizio Merli, Manuela Can J Gastroenterol Hepatol Research Article Cardiovascular diseases are currently one of the most important causes of morbidity and mortality in liver transplant patients over the long term. Therefore, evaluating prognostic factors for cardiovascular events (CVEs) in this population is essential for taking preventive measures. The aim of this study was to identify the impact of diabetes and other metabolic disorders on CVEs in liver transplant patients. Three hundred fifty-six liver transplant recipients who survived at least 6 months after surgery were enrolled. Patients were followed for a median time of 118 months (12–250 months). All cardiovascular events were carefully recorded and detailed in the patients' charts. Demographic data, diabetes, hypertension, dyslipidemia, weight changes, and a diagnosis of metabolic syndrome both before and after transplantation were noted to assess their possible relationship with CVE. The presence of a diagnosis of metabolic-associated fatty liver disease (MAFLD) was also evaluated. Immunosuppressive therapy was included in the analysis. Diabetes mellitus (DM), especially when present before transplantation, was strongly associated with CVEs (hazard risk HR 3.10; 95% confidence interval CI: 1.60–6.03). Metabolic syndrome was found to be associated with CVEs in univariate analysis (HR 3.24; 95% CI: 1.36–7.8), while pretransplantation and de novo MAFLD were not. Immunosuppressive therapy had no influence on predisposing transplanted patients to CVEs during follow-up. Further prospective studies may be useful in investigating the risk factors for CVEs after liver transplantation and improving the long-term survival of transplant patients. Hindawi 2023-06-23 /pmc/articles/PMC10313467/ /pubmed/37396501 http://dx.doi.org/10.1155/2023/2199193 Text en Copyright © 2023 Simone Di Cola et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Di Cola, Simone
Cusi, Giulia
Lapenna, Lucia
Gazda, Jakub
Fonte, Stefano
Mattana, Marco
Mennini, Gianluca
Pasqualetti, Patrizio
Merli, Manuela
Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title_full Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title_fullStr Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title_full_unstemmed Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title_short Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients
title_sort diabetes and metabolic disorders: their impact on cardiovascular events in liver transplant patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10313467/
https://www.ncbi.nlm.nih.gov/pubmed/37396501
http://dx.doi.org/10.1155/2023/2199193
work_keys_str_mv AT dicolasimone diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT cusigiulia diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT lapennalucia diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT gazdajakub diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT fontestefano diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT mattanamarco diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT menninigianluca diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT pasqualettipatrizio diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients
AT merlimanuela diabetesandmetabolicdisorderstheirimpactoncardiovasculareventsinlivertransplantpatients